Rchr
J-GLOBAL ID:201601014058839510   Update date: Feb. 01, 2024

Yamazaki Yuichi

ヤマザキ ユウイチ | Yamazaki Yuichi
Affiliation and department:
Job title: Associate Professor
Research field  (1): Gastroenterology
Research theme for competitive and other funds  (9):
  • 2022 - 2025 サルコペニア高齢者の薬物代謝能力及び相互作用評価システムの開発と副作用リスク回避
  • 2020 - 2023 転写共役活性化因子PDIP1による普遍的酸化ストレス調節能の検証と標的分子探索
  • 2020 - 2023 腸内フローラの破綻時の胆管障害における核内受容体CAR/PXRの役割
  • 2017 - 2022 肝前駆細胞を介した胆管上皮細胞増殖、胆管形成、再生における核内受容体CARの役割
  • 2017 - 2021 The role of nuclear receptor CAR in the pathogenesis of intrahepatic cholangiocellular carcinoma
Show all
Papers (49):
  • Satoshi Takakusagi, Hitoshi Takagi, Yuichi Yamazaki, Takashi Kosone, Shigeo Nagashima, Masaharu Takahashi, Kazumoto Murata, Hiroaki Okamoto. Chronic hepatitis E in an elderly immunocompetent patient who achieved a sustained virologic response with ribavirin treatment. Clinical journal of gastroenterology. 2023. 16. 2. 206-215
  • Ken Sato, Yuichi Yamazaki, Yuki Kanayama, Daisuke Uehara, Hiroki Tojima, Takayoshi Suga, Satoru Kakizaki, Naondo Sohara, Norio Horiguchi, Toshio Uraoka. Adolescents with chronic hepatitis C might be good candidates for direct-acting antiviral therapy. Clinical case reports. 2022. 10. 4. e05690
  • Yuichi Yamazaki, Yuki Kanayama, Daisuke Uehara, Takayoshi Suga, Hirohito Tanaka, Hiroki Tojima, Shiko Kuribayashi, Ken Sato, Satoru Kakizaki, Toshio Uraoka. [Liver injury in patients with moderate II COVID-19 who received dexamethasone monotherapy]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology. 2022. 119. 4. 332-341
  • Ken Sato, Yuichi Yamazaki, Toshio Uraoka. Strategy for the control of drug-induced liver injury due to investigational treatments/drugs for COVID-19. World journal of gastroenterology. 2021. 27. 48. 8370-8373
  • Takeshi Hatanaka, Satoru Kakizaki, Takuya Kaburagi, Naoto Saito, Sachi Nakano, Yoichi Hazama, Sachiko Yoshida, Yoko Hachisu, Yoshiki Tanaka, Teruo Yoshinaga, et al. Chronic Infection with Hepatitis C Virus Subtype 1 g in a Japanese Patient Successfully Treated with Glecaprevir/Pibrentasvir. Internal medicine (Tokyo, Japan). 2021. 61. 10. 1537-1543
more...
MISC (151):
more...
Lectures and oral presentations  (17):
  • 当院におけるアルコール関連疾患及び肝疾患の現状
    (第109回日本消化器病学会総会 2023)
  • An autopsy case of multicentric Castleman disease presenting with severe jaundice
    (APASL2022 2022)
  • 全科協力体制下でのCOVID-19診療における内科医かつ消化器内科医の役割
    (第63回 日本消化器病学会大会 2021)
  • Characteristics of cases of hepatitis E in Gunma prefecture: small epidemics caused by the same subgenotype 3a strains.
    (APDW2021 2021)
  • 群馬県におけるE型肝炎の最新の動向
    (第56回日本肝臓学会総会 2020)
more...
Professional career (1):
  • MD (Gunma University)
Work history (2):
  • 2008 - 2010 米国国立衛生研究所、国立環境衛生研究所
  • 2008 - 2010 NIH/NIEHS
Committee career (3):
  • 2020/12 - 日本消化器内視鏡学会関東支部 評議員
  • 日本消化器病学会関東支部 評議員
  • 日本肝臓学会東部会 評議員
Association Membership(s) (5):
日本消化器内視鏡学会 関東支部 ,  日本内科学会 ,  日本消化器内視鏡学会 ,  日本消化器病学会 ,  日本肝臓学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page